173 Indian IPOs are SEBI-approved and unlisted. The clock on that approval does not reset twice.

The backlog looks like a parking lot. It runs like a countdown.

As of 19 June 2026, 173 companies were sitting on live SEBI IPO approval to raise close to ₹2.7 lakh crore through initial public offerings, and had not listed. Another 64 companies, worth roughly ₹1.95 lakh crore between them, were still waiting for that approval to come through. Coverage of the backlog has settled into a single frame: a queue of ready offerings, paused until investor sentiment recovers enough to absorb them, with the second half of 2026 pencilled in as the moment it finally clears.

Some of the names attached to that second-half optimism are large enough to explain the mood: Reliance Jio, the National Stock Exchange, and the quick-commerce platform Zepto have all been named in market reporting as candidates for a 2026 listing, alongside an asset manager, SBI Mutual Fund. When reporters and analysts talk about the backlog "clearing," they generally mean these few headline names finally pulling the trigger, with the other 170-odd approved companies assumed to follow once the big listings prove the market is open again.

That framing treats SEBI approval as a banked right a company can cash in whenever the market looks better. It is not. The observation letter that actually lets a company open its IPO comes with an expiry date, and SEBI has exactly one precedent on record for moving that date. It already used it.

What an SEBI IPO approval actually buys a company

Under Regulation 44 of the SEBI (ICDR) Regulations, 2018, a standard observation letter is valid for 12 months from the date it is issued. Companies that file confidentially through SEBI's pre-filing route get a longer runway, 18 months, which is the main reason some larger issuers choose that route over the public one. Either way, the clock starts when SEBI signs off, not when the company decides conditions look favourable. If the IPO has not opened by the deadline, the approval lapses.

That detail rarely surfaces in backlog coverage, because most of the 173 companies in the queue received their approvals recently enough that the clock has not mattered yet. It is about to. And the review process that produces an observation letter in the first place is not instant either: SEBI typically takes around 70 working days to respond to a draft prospectus with comments, longer if it raises follow-up queries. A company that refiles after lapsing is not rejoining a fast-moving line. It is rejoining a slow one, from the back.

It is also worth separating mainboard issuers from the SME platform, where the same mechanics apply on a smaller scale. Stock exchanges, following SEBI's lead, gave roughly 10 to 15 SME issuers the same one-time extension to 30 September, for the same stated reasons. That means two parallel backlogs, mainboard and SME, are both converging on one calendar date rather than spreading their risk across the year the way a healthier market would.

SEBI already spent its one available lever

In April 2026, SEBI granted a one-time relief: any observation letter due to expire between 1 April and 30 September 2026 would instead remain valid until 30 September 2026, a window the regulator tied directly to West Asia geopolitical tension and foreign-investor outflows that it said were pushing issuers to defer or withdraw listing plans rather than use approvals they already held. SEBI also instructed stock exchanges not to penalise companies for breaching minimum public shareholding norms before the same date, stacking one relaxed deadline on top of another.

Minimum public shareholding rules require listed companies to get at least 25% of their shares into public hands within a set timeline after listing. Pausing enforcement of that rule alongside the observation-letter extension was SEBI signalling that the entire compliance calendar around this stretch of the market, not just the IPO clock, needed slack.

Industry estimates compiled around the announcement put roughly 40 issuers, worth a combined ₹43,500 crore, inside the window that got extended. That is a meaningful slice of the backlog. It is not most of it, which is the part the calm-queue framing misses.

"One-time" is the operative phrase

SEBI was explicit that the extension was a one-off, not a standing policy. There is no recent precedent for a second extension once 30 September arrives, and nothing in the regulator's public statements suggests one is coming. For the roughly 40 issuers whose clocks were originally due to run out earlier this year, the wall has not disappeared. It has moved six months down the road, onto a single date that now applies to all of them at once.

The maths nobody in the "queue" framing has run

Stack the three populations next to each other and the backlog stops looking like a calm waiting room.

Layer that against actual listing activity: only 26 mainboard IPOs reached the market in the first half of 2026. If even a fraction of the approved-but-unlisted group lists inside the same few months to beat its own expiry dates, rather than because sentiment has genuinely turned, that is a multi-lakh-crore supply event hitting a market that has been absorbing well under half its usual mainboard volume. Nobody has published a model for what a compressed listing calendar like that does to pricing or allotment, because most coverage treats the trigger, a wave of approvals expiring at once, as good news rather than as a deadline.

What a lapsed approval actually costs

An expired observation letter is not a renewal form. It is a restart. The company has to refile a draft red herring prospectus with updated, restated financials, get its lead managers to resubmit due-diligence sign-offs, and go through SEBI's review process again, a cycle that, under normal conditions, runs several months on its own before a fresh observation letter is even issued. A company that has been 'IPO-ready' for a year does not lose a few weeks if its window closes. It loses its place in line and restarts the process with financials that may no longer reflect the business it has become.

Restated financials are the expensive part, not the paperwork. SEBI requires the numbers in an offer document to be current within a set number of months of the issue opening. A company that planned its IPO around one financial year and missed its window by even a couple of quarters typically needs a fresh statutory audit cycle bolted onto the refiling, with the lead managers re-running due diligence against numbers that have moved. None of that is optional, and none of it is fast, which is exactly why 'just refile' undersells what a lapsed approval actually triggers.

What this means if you are inside the queue, not reading about it

For a founder or CFO holding live SEBI approval, the practical question is not whether sentiment has recovered enough. It is what date sits on the observation letter, and whether there is a path to list before it, independent of whether this is the ideal week to do it. Waiting for a perfect market and running out a 12-month clock are different decisions, even though most boardroom conversations currently treat them as the same one.

For investors holding pre-IPO positions, venture or private equity, the same recalculation applies in reverse. An exit that depends on a portfolio company listing inside a specific window has a different risk profile than one that depends on the market improving sometime in 2026. The first has a date attached to it. It should be modelled like one, not folded into a general sentiment forecast.

It also explains why more issuers are likely to lean on the confidential pre-filing route going forward. The extra six months of runway it carries over the public filing process used to be a minor administrative preference. After this year, it looks more like the only structural hedge against exactly this kind of squeeze.

Underwriters and lead managers have a related incentive to start mapping client expiry dates now rather than in August. A bank that waits until the weeks before 30 September to find out which of its mandates are about to lapse is choosing to discover the problem at the same moment dozens of other banks discover it for their own clients, competing for the same printers, the same anchor investors, and the same limited run of trading days before the deadline.

The real test arrives at the next deadline, not before it

Whether India's IPO market improves in the second half of 2026 will get measured in listing counts and subscription numbers, and that is the metric most coverage is already tracking. The sharper test is what SEBI does the next time a batch of approvals, including the roughly 40 it just bought six extra months for, runs up against a deadline the regulator already called one-time.